The Role of Neurodevelopmental Pathways in Brain Tumors
Rachel N Curry1,2, Stacey M Glasgow3,4,5
1Department of Neuroscience, Baylor College of Medicine, Center for Cell and Gene Therapy, Houston, TX, United States.
Abstract:
Disruptions to developmental cell signaling pathways and transcriptional cascades have been implicated in tumor initiation, maintenance and progression. Resurgence of aberrant neurodevelopmental programs in the context of brain tumors highlights the numerous parallels that exist between developmental and oncologic mechanisms. A deeper understanding of how dysregulated developmental factors contribute to brain tumor oncogenesis and disease progression will help to identify potential therapeutic targets for these malignancies. In this review, we summarize the current literature concerning developmental signaling cascades and neurodevelopmentally-regulated transcriptional programs. We also examine their respective contributions towards tumor initiation, maintenance, and progression in both pediatric and adult brain tumors and highlight relevant differentiation therapies and putative candidates for prospective treatments.
Insights
Aberrant neurodevelopmental programs drive brain tumor growth. Understanding these disruptions offers new therapeutic targets for brain cancer treatment.
Area of Science:
- Neuro-oncology
- Developmental Biology
- Cancer Genetics
Background:
- Disruptions in developmental cell signaling pathways and transcriptional cascades are linked to cancer initiation and progression.
- Aberrant neurodevelopmental programs are frequently observed in brain tumors, indicating shared mechanisms between development and oncogenesis.
- Understanding these dysregulated developmental factors is crucial for identifying novel therapeutic strategies for brain malignancies.
Purpose of the Study:
- To review current literature on developmental signaling and neurodevelopmental transcriptional programs in brain tumors.
- To examine the role of these programs in tumor initiation, maintenance, and progression across pediatric and adult brain tumors.
- To highlight potential differentiation therapies and therapeutic targets for brain cancer treatment.
Main Methods:
- Comprehensive literature review of studies investigating developmental pathways in brain tumors.
- Analysis of neurodevelopmentally-regulated transcriptional programs in the context of oncogenesis.
- Examination of therapeutic strategies targeting differentiation pathways.
Main Results:
- Evidence supports the significant contribution of disrupted developmental pathways to brain tumor development.
- Shared molecular mechanisms exist between normal neurodevelopment and brain tumor progression.
- Specific developmental programs are implicated in both pediatric and adult brain tumor subtypes.
Conclusions:
- Dysregulated developmental programs are key drivers of brain tumor oncogenesis and progression.
- Targeting these aberrant developmental pathways holds promise for novel brain cancer therapies.
- Further research into differentiation therapies could lead to improved patient outcomes.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Neurulation
Neurogenesis and Regeneration of Nervous Tissue
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...


